IRIS

1.1 Articolo in rivista: [26919] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 13.341 a 13.360 di 26.919
Titolo Data di pubblicazione Autore(i) File
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association 1-gen-2022 Costantino, A.; Noviello, D.; Conforti, F. S.; Aloi, M.; Armuzzi, A.; Bossa, F.; Ficari, F.; Leone, S.; Manguso, F.; Mocci, G.; Orlando, A.; Pironi, L.; Radice, S.; Rizzello, F.; Tongiorgi, A.; Costantino, C.; Vecchi, M.; Caprioli, F.
Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease 1-gen-2006 Guidi, L; De Franco, A; De Vitis, I; Armuzzi, A; Semeraro, S; Roberto, I; Papa, A; Bock, E; Gasbarrini, G; Fedeli, G
The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe 1-gen-2020 Armuzzi, A; Tarallo, M; Lucas, J; Bluff, D; Hoskin, B; Bargo, D; Cappelleri, Jc; Salese, L; daCosta DiBonaventura, M
Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review 1-gen-2019 Macaluso, Fs; Cavallaro, F; Felice, C; Mazza, M; Armuzzi, A; Gionchetti, P; Vecchi, M; Orlando, A
Infliximab: A review of its use in the treatment of inflammatory Bowel disease 1-gen-2011 Marzo, M; Felice, C; Rapaccini, Gl; Guidi, L; Armuzzi, A
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center 1-gen-2020 Lopetuso, Lr; Scaldaferri, F; Ianiro, G; Bibbò, S; Settanni, Cr; Papa, A; Armuzzi, A; Gasbarrini, A; Cammarota, G
Adalimumab in the treatment of immune-mediated diseases 1-gen-2014 Lapadula, G; Marchesoni, A; Armuzzi, Alessandro; Blandizzi, C; Caporali, R; Chimenti, S; Cimaz, R; Cimino, L; Gionchetti, P; Girolomoni, G; Lionetti, P; Marcellusi, A; Mennini, Fs; Salvarani, C.
Role of sucralfate in gastrointestinal diseases 1-gen-2000 Candelli, M; Carloni, E; Armuzzi, A; Cammarota, G; Ojetti, V; Pignataro, G; Santoliquido, A; Pola, R; Pola, E; Gasbarrini, G; Gasbarrini, A
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus 1-gen-2000 Gasbarrini, A; Ojetti, V; Pitocco, D; Armuzzi, A; Silveri, Ng; Pola, P; Ghirlanda, C; Gasbarrini, G
Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura 1-gen-2000 Gasbarrini, A; Gabrielli, M; Fiore, G; Candelli, M; Bartolozzi, F; De Luca, A; Cremonini, F; Franceschi, F; Di Campli, C; Armuzzi, A; Ojetti, V; Serricchio, M; Pola, R; Gasbarrini, G; Giacovazzo, M; Pola, P
Implementing the Concept of Continuous Clinical Response Into Clinical Practice for Ulcerative Colitis 1-gen-2017 Peyrin-Biroulet, L; Van Assche, G; Armuzzi, A; Garcia-Alvarez, L; Lara, N; Black, Cm; Khalifa, A; Cornillie, F; Kachroo, S
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 1-gen-2013 Andrisani, Gianluca; Gremese, Elisa; Guidi, Luisa; Papa, Alfredo; Marzo, Manuela; Felice, Carla; Pugliese, Daniela; Armuzzi, Alessandro
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 1-gen-2021 Pugliese, D; Guidi, L; Privitera, G; Bertani, L; Tolusso, B; Papparella, Lg; Maltinti, S; Di Mario, C; Onali, S; Ceccarelli, L; Rapaccini, Gl; Scaldaferri, F; Gremese, E; Gasbarrini, A; Costa, F; Armuzzi, A
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease 1-gen-2014 Rahier, Jf; Magro, F; Abreu, C; Armuzzi, Alessandro; Ben Horin, S; Chowers, Y; Cottone, M; De Ridder, L; Doherty, G; Ehehalt, R; Esteve, M; Katsanos, K; Lees, Cw; Macmahon, E; Moreels, T; Reinisch, W; Tilg, H; Tremblay, L; Veereman Wauters, G; Viget, N; Yazdanpanah, Y; Eliakim, R; Colombel, Jf
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 1-gen-2014 Armuzzi, Alessandro; Lionetti, P; Blandizzi, C; Caporali, R; Chimenti, S; Cimino, L; Gionchetti, P; Girolomoni, G; Lapadula, G; Marchesoni, A; Marcellusi, A; Mennini, Fs; Salvarani, C; Cimaz, R.
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease 1-gen-2014 Palone, F; Vitali, R; Cucchiara, S; Pierdomenico, M; Negroni, A; Aloi, M; Nuti, F; Felice, C; Armuzzi, Alessandro; Stronati, L.
Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis 1-gen-2018 Alivernini, S; Pugliese, D; Tolusso, B; Bui, L; Petricca, L; Guidi, L; Mirone, L; Rapaccini, Gl; Federico, F; Ferraccioli, G; Armuzzi, A; Gremese, E
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management 1-gen-2021 Sands, Be; Colombel, Jf; Ha, C; Farnier, M; Armuzzi, A; Quirk, D; Friedman, Gs; Kwok, K; Salese, L; Su, C; Taub, Pr
Update on the management of inflammatory bowel disease: specific role of adalimumab 1-gen-2011 Guidi, L; Pugliese, D; Armuzzi, A
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 1-gen-2021 Festa, S; Scribano, Ml; Pugliese, D; Bezzio, C; Principi, M; Ribaldone, Dg; Allocca, M; Mocci, G; Bodini, G; Spagnuolo, R; Vernia, P; Mazzuoli, S; Costa, F; Barberio, B; Cosintino, R; Zerboni, G; Aratari, A; Armuzzi, A; Papi, C
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 13.341 a 13.360 di 26.919
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista26919
Autore
  • OYEN, Willem Jozef Gerard891
  • SANTORO, Armando806
  • CANONICA, Giorgio775
  • REPICI, Alessandro723
  • HASSAN, CESARE690
  • DANESE, Silvio643
  • FASANO, ALFONSO471
  • Marcacci, Maurilio467
  • D'INCALCI, MAURIZIO466
  • LAGHI, ANDREA457
Data di pubblicazione
  • In corso di stampa6
  • 2020 - 20269123
  • 2010 - 201911532
  • 2000 - 20094500
  • 1990 - 19991429
  • 1980 - 1989306
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE368
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
  • ANNALS OF ONCOLOGY243
  • CANCERS228
  • THE JOURNAL OF NUCLEAR MEDICINE220
  • PLOS ONE212
  • EUROPEAN JOURNAL OF CANCER205
  • GASTROINTESTINAL ENDOSCOPY193
  • JOURNAL OF CLINICAL MEDICINE184
  • ALLERGY180
Keyword
  • Humans2101
  • Female1005
  • Male964
  • Middle Aged745
  • Aged643
  • Adult550
  • COVID-19415
  • Treatment Outcome359
  • Animals321
  • Retrospective Studies262
Lingua
  • eng19197
  • ita408
  • spa14
  • fre11
  • ger8
  • enm3
  • por2
  • chi1
Accesso al fulltext
  • no fulltext24666
  • reserved1362
  • open891